The private sector: MNEs and SMEs

Handbook on Agriculture, Biotechnology and Development

Volumn , Issue , 2014, Pages 56-70

  Hobbs, Jill E ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957999056     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4337/9780857938350.00009     Document Type: Chapter

References (39)

1. Antoncic, B. (2001), ‘Organisational processes in intrapreneurship: a conceptual integration’, Journal of Enterprising Culture, 9 (2) 221-35.
2. BA SF (2011), ‘BA SF factbook 2011: we create chemistry’, Ludwigshafen, Germany: BA SF SE, Investor Relations, available at: www.basf.com. accessed 29 January 2012.
3. BA SF (2012), ‘BA SF to concentrate plant biotechnology activities on main markets in North and South America’, BA SF News Release, 16 January 2012, Ludwigshafen, Germany BA SF SE: available at: www.basf.com/group/pressrelease/P-12-109, accessed 1 October 2012.
4. Bayer (2011), ‘Bayer 2010 Annual Report’, Leverkusen, Germany: Bayer AG, available at: www.bayer.com, accessed 29 January 2012.
5. Blank, S.C. (2008), ‘Insiders’ views on business models used by small agricultural biotechnology firms: economic implications for the emerging global industry’, Agbioforum, 11 (2), 71-81.
6. Bonnafous-Boucher, M. and E. Lamy (2010), ‘Hybridisation of the profiles of entrepreneurs and intrapreneurs: the case of French biotechnology SMEs’, International Journal of Entrepreneurship and Small Business, 10 (3), 410-27.
7. Brennan, M., C. Pray, A. Naseem and J.F. Oehmke (2005), ‘An innovation market approach to analyzing impacts of mergers and acquisitions in the plant biotechnology industry’, Agbioforum, 8 (2&3), 89-99.
8. Deeds, D.L. and C.W.L. Hill (1996), ‘Strategic alliances and the rate of new product development: an empirical study of entrepreneurial biotechnology firms’, Journal of Business Venturing, 11 (1), 41-55.
9. Dow (2011), ‘The right formula for growth: the Dow Chemical Company 2010 annual report’, Midland, MO: The Dow Chemical Company, available at: www.dow.com/financial, accessed 29 January 2012.
10. Dutfield, G. (2008), ‘Turning plant varieties into intellectual property: the UPOV convention’, in G. Tansey and T. Rajotte (eds), The Future Control of Food: A Guide to International Negotiations and Rules on Intellectual Property, Biodiversity and Food Security, London: Earthscan, pp. 27-47.
11. Frisio, D.G., G. Ferrazzi, V. Ventura and M. Vigani (2010), ‘Public vs. private agbiotech research in the United States and European Union, 2002-2009', Agbioforum, 13 (4), 333-42.
12. Gaisford, J.D., J.E. Hobbs, W.A. Kerr, N. Perdikis and M. Plunkett (2001), The Economics of Biotechnology, Cheltenham, UK and Northampton, MA, USA: Edward Elgar Publishing.
13. Han, K.J., N. Kim and R.K. Srivastava (1998), ‘Market orientation and organizational performance: is innovation a missing link?' Journal of Marketing, 62 (4), 30-45.
14. Hayenga, M. (1998), ‘Structural change in the biotech seed and chemical industry complex’, Agbioforum, 1 (2), 43-55.
15. Hirschman, A.O. (1964), ‘The paternity of an index’, The American Economic Review, 54 (5), 761.
16. Hobbs, J.E. and W.A. Kerr (2003), ‘Biotechnology and the changing structure of agri-food supply chains’, International Journal of Biotechnology, 5 (3/4), 297-310.
17. Kalaitzandonakes, N. and M. Hayenga (2000), ‘Structural changes in the biotechnology and seed industrial complex: theory and evidence’, in W.H. Lesser (ed.), Transitions in Agbiotech: Economics of Strategy and Policy, Storrs, CT: Food Marketing Policy Center, University of Connecticut, pp. 217-27.
18. King, J.L. and D. Schimmelpfennig (2005), ‘Mergers, acquisitions, and stocks of agricultural biotechnology intellectual property’, Agbioforum, 8 (2&3), 83-8.
19. Kirca, A.H., S. Jayachandran and W.O. Bearden (2005), ‘Market orientation: a meta-analytic review and assessment of its antecedents and impact on performance’, Journal of Marketing, 69(2), 24-41.
20. Klein, B., R.G. Crawford and A.A. Alchian (1978), ‘Vertical integration, appropriable rents, and the competitive contracting process’, Journal of Law and Economics, 21(2), 297-326.
21. Lukas, B.A. and O.C. Ferrell (2000), ‘The effect of market orientation on product innovation’, Academy of Marketing Science Journal, 28(2), 239-47.
22. Marks, L.A., B. Freeze and N. Kalaitzandonakes (1999), ‘The agbiotech industry-a US-Canadian perspective’, Canadian Journal of Agricultural Economics, 47(4), 419-31.
23. Monsanto (2011a), ‘Leading in innovation: 2011 annual report-Monsanto’, St Louis, MO: Monsanto, available at: www.monsanto.com, accessed 29 January 2012.
24. Monsanto (2011b), ‘Monsanto 2011 Form 10-K’, St Louis, MO: Monsanto, available at: www.monsanto.com, accessed 29 January 2012.
25. Niosi, J. and J. Queenton (2010), ‘Knowledge capital in biotechnology industry: impacts on Canadian firm performance’, International Journal of Knowledge-Based Development, 1(1/2), 136-51.
26. OECD (2005), OECD SME and Entrepreneurship Outlook, Paris: Organisation for Economic Co-operation and Development.
27. Oehmke, J.F. and C.A. Wolf (2003), ‘Measuring concentration in the biotechnology R&D industry: adjusting for interfirm transfer of genetic materials’, Agbioform, 6(3), 134-40.
28. Peña, I. (2009), ‘Intrepreneurial strategic behaviour and business performance’, International Journal of Entrepreneurship and Innovation Management, 10(1), 3-19.
29. Phillips, P.W.B. and G.G. Khachatourians (eds) (2001), The Biotechnology Revolution in Global Agriculture: Innovation, Invention and Investment in the Canola Sector, Wallingford: CABI Publishing.
30. Phillips, P.W.B. and C. Ryan (2007), ‘The role of clusters in driving innovation’, in A. Krattiger, R.T. Mahoney and L. Nelson (eds), Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices, Oxford: MIHR and Davis, CA: PIPRA, pp. 281-94.
31. Pray, C. and A. Naseem (2005), ‘Intellectual property rights on research tools: incentives or barriers to innovation? Case studies of rice genomics and plant transformation technologies’, Agbioforum, 8(2&3), 108-17.
32. Pray, C., J.F. Oehmke and A. Naseem (2005), ‘Innovation and dynamic efficiency in plant biotechnology: an introduction to the researchable issues’, Agbioforum, 8(2&3), 52-63.
33. Renko, M., A. Carsrud and M. Brännback (2009), ‘The effect of market orientation, entrepreneurial orientation, and technological capability on innovativeness: a study of young biotechnology ventures in the United States and Scandinavia’, Journal of Small Business Management, 47(3), 331-69.
34. Rhoades, S.A. (1995), ‘Market share inequality, the HHI and other measures of the firm-composition of a market’, Review of Industrial Organization, 10(6), 657-74.
35. Smyth, S.J. and R. Gray (2011), ‘Intellectual property sharing agreements in gene technology: implications for research and commercialisation’, International Journal of Intellectual Property Management, 4(3), 179-90.
36. Syngenta (2011), ‘Syngenta annual review 2010', Basel: Syngenta International AG available at: www.syngenta.com, accessed 29 January 2012.
37. Teece, D.J. and G. Pisano (1994), ‘The dynamic capability of firms: an introduction’, Industrial and Corporate Change, 3(3), 537-56.
38. Williamson, O.E. (1979), ‘Transaction-cost economics: the governance of contractual relations’, Journal of Law and Economics, 22(2), 233-61.
39. Zucker, L., M. Darby and M. Brewer (1998), ‘Intellectual human capital and the birth of US biotechnology enterprises’, American Journal of Economics, 88(1), 290-306.